Atlas Trials

Postoperative Adjuvant Therapy for Non-clear Renal Cell Carcinoma With High-risk Recurrence Factors

Clinical trial NCT05768464 · RECRUITING

Trial details

NCT number
NCT05768464
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Non-clear Renal Cell Carcinoma
Start date
2023-02-01
Primary completion
2026-12-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.